-
Founded in:
1998-10-26 -
Country:
China -
Address:
No. 2899, Macheng Road, Majinpu, High-tech Zone, Kunming City, Yunnan Province -
Tax NO.:
915300007097131980 -
Registered Funds:
131.12 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Tetracycline |
It has a broad spectrum of anti-pathogenic microorganisms and is an antibacterial agent. It has a bactericidal effect at high concentrations. Its mechanism of action is that the drug can specifically bind to the A position of the bacterial ribosome 30S subunit, preventing the connection of aminoacyl-tRNA at this position, thereby inhibiting the growth of peptide chains and affecting the protein synthesis of bacteria or other pathogenic microorganisms.
More
It has a broad spectrum of anti-pathogenic microorganisms and is an antibacterial agent. It has a bactericidal effect at high concentrations. Its mechanism of action is that the drug can specifically bind to the A position of the bacterial ribosome 30S subunit, preventing the connection of aminoacyl-tRNA at this position, thereby inhibiting the growth of peptide chains and affecting the protein synthesis of bacteria or other pathogenic microorganisms. |
60-54-8 | 25 | |
| Cortisone acetate |
It is a type of adrenal cortex hormone drug with anti-inflammatory and anti-allergic effects. It can inhibit the proliferation of connective tissue, reduce the permeability of capillary walls and cell membranes, reduce inflammatory exudation, and inhibit the formation and release of histamine and other toxic substances.
More
It is a type of adrenal cortex hormone drug with anti-inflammatory and anti-allergic effects. It can inhibit the proliferation of connective tissue, reduce the permeability of capillary walls and cell membranes, reduce inflammatory exudation, and inhibit the formation and release of histamine and other toxic substances. |
50-04-4 | 11 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Lamiophlomis Herba |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Lampleaf Extract |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clindamycin phosphate |
This product is a semi-synthetic clindamycin derivative and a narrow-spectrum antibiotic. This product has strong antibacterial activity against Gram-positive cocci and anaerobic bacteria. In vitro tests show that this product has the effect of inhibiting the growth of Propionibacterium acnes, Propionibacterium granulosum, Staphylococcus aureus, Staphylococcus epidermidis, etc.
More
This product is a semi-synthetic clindamycin derivative and a narrow-spectrum antibiotic. This product has strong antibacterial activity against Gram-positive cocci and anaerobic bacteria. In vitro tests show that this product has the effect of inhibiting the growth of Propionibacterium acnes, Propionibacterium granulosum, Staphylococcus aureus, Staphylococcus epidermidis, etc. |
24729-96-2 | 33 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Erigeron breviscapus extract |
1. Effects on the cardiovascular system: can enhance coronary flow, dilate coronary arteries, reduce the scope of myocardial infarction, promote the opening of coronary collateral circulation, slow down heart rate, reduce myocardial contractility, reduce myocardial oxygen consumption and work, and protect cardiac cell membranes; 2. Anticoagulant, antithrombotic and fibrinolytic activity effects: inhibit platelet aggregation, prolong thrombosis time, reduce thrombus weight, and promote fibrinolytic activity; 3. Effects on microcirculation and hemorheology: improve microcirculatory disorders and reduce whole blood viscosity; 4. Cerebral vascular dilation effect: reduce cerebral vascular tension and dilate cerebral blood vessels; 5. Other effects: increase the permeability of the blood-brain barrier, inhibit protein kinase C, counteract platelet aggregation, and improve immune function; 6. In vivo process: the drug is distributed rapidly in the body and is mainly excreted through bile and feces; 7. Toxicity: acute toxicity is low, and subacute toxicity tests did not show significant effects on blood counts, liver and kidney functions.
More
1. Effects on the cardiovascular system: can enhance coronary flow, dilate coronary arteries, reduce the scope of myocardial infarction, promote the opening of coronary collateral circulation, slow down heart rate, reduce myocardial contractility, reduce myocardial oxygen consumption and work, and protect cardiac cell membranes; 2. Anticoagulant, antithrombotic and fibrinolytic activity effects: inhibit platelet aggregation, prolong thrombosis time, reduce thrombus weight, and promote fibrinolytic activity; 3. Effects on microcirculation and hemorheology: improve microcirculatory disorders and reduce whole blood viscosity; 4. Cerebral vascular dilation effect: reduce cerebral vascular tension and dilate cerebral blood vessels; 5. Other effects: increase the permeability of the blood-brain barrier, inhibit protein kinase C, counteract platelet aggregation, and improve immune function; 6. In vivo process: the drug is distributed rapidly in the body and is mainly excreted through bile and feces; 7. Toxicity: acute toxicity is low, and subacute toxicity tests did not show significant effects on blood counts, liver and kidney functions. |
0 |